Please login to the form below

Not currently logged in
Email:
Password:

Melinta

This page shows the latest Melinta news and features for those working in and with pharma, biotech and healthcare.

Cubist gets green light from FDA for new antibiotic Sivextro

Cubist gets green light from FDA for new antibiotic Sivextro

2020. Other drugs in development to treat ABSSSIs include Furiex Pharmaceuticals' avarofloxacin (phase III), Melinta Therapeutics' delafloxacin (phase III) and The Medicines Company's oritavancin (filed for approval in the US).

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Melinta names chief medical officer Melinta names chief medical officer

    Melinta names chief medical officer. Sue Cammarata has experience at Shire and Novartis. ... Dr Sue Cammarata has joined Melinta Therapeutics as chief medical officer as the company advances the progress of its late-stage pipeline.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics